A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer - Concepedia

Concepedia

Publication | Open Access

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer

DOI Full Paper Access

64

Citations

37

References

2013

Year

Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca,

Cancer Immunology Immunotherapy

UrologyCancer ImmunosurveillanceGenitourinary CancerImmunologyTherapeutic VaccineImmune Checkpoint InhibitorRenal CancerImmunotherapyMedicineDual-adjuvant Telomerase VaccineTumor Microenvironment

References

	Year	Citations

Page 1

Page 1